BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34457)

  • 1. beta-Adrenoceptor blocking drugs and isoprenaline: central effects on cardiovascular parameters.
    Cohen Y; Lindenbaum A; Midol-Monnet M; Porquet D; Wepierre J
    Br J Pharmacol; 1979 Mar; 65(3):389-94. PubMed ID: 34457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiohemodynamic effects of bopindolol in normotensive conscious dogs. A comparative study with pindolol.
    Ishibashi T; Mitomi A; Tatebe S; Imai S
    Arzneimittelforschung; 1989 Apr; 39(4):454-7. PubMed ID: 2568836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
    van den Meiracker AH; Man in't Veld AJ; Boomsma F; Fischberg DJ; Molinoff PB; Schalekamp MA
    Circulation; 1989 Oct; 80(4):903-14. PubMed ID: 2571431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects of beta-adrenergic blockade with pindolol, oxprenolol, propranolol and bufetolol hydrochloride in essential hypertension.
    Tsukiyama H; Otsuka K; Miyamoto K; Hashimoto M; Yasutake S
    Jpn Circ J; 1976 Jun; 40(6):655-64. PubMed ID: 7688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac and renovascular effects in the anaesthetized dog of BW A575C: a novel angiotensin converting enzyme inhibitor with beta-adrenoceptor blocking properties.
    Cambridge D; Whiting MV; Allan G
    Br J Pharmacol; 1988 Jan; 93(1):165-75. PubMed ID: 2894874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of propranolol-sensitive beta-adrenoceptor signaling after inhibition of nitric oxide synthesis.
    Whalen EJ; Bates JN; Johnson AK; Lewis SJ
    Br J Pharmacol; 2006 Apr; 147(7):755-64. PubMed ID: 16474417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the stereoisomers of beta-adrenoceptor antagonists in conscious A-V blocked dogs.
    Boucher M; DuchĂȘne-Marullaz P; Moundanga JL
    Br J Pharmacol; 1986 Sep; 89(1):119-27. PubMed ID: 2879587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic antagonism of beta-adrenergic blockade in dogs. I. Hemodynamic effects of isoproterenol, dopamine, and epinephrine in acute propranolol administration.
    Avery GJ; Spotnitz HM; Rose EA; Malm JR; Hoffman BF
    J Thorac Cardiovasc Surg; 1979 Feb; 77(2):267-76. PubMed ID: 33298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in haemodynamic response to beta-blocking drugs between stable coronary artery disease and acute myocardial infarction.
    Silke B; Frais MA; Verma SP; Reynolds G; Taylor SH
    Eur J Clin Pharmacol; 1986; 29(6):659-65. PubMed ID: 2872054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of propranolol and pindolol on the haemodynamic effects of papaverine, isoprenaline and noradrenaline in hypertensive patients.
    Chu D; Cocco G; Schweda E; Haeusler G; Strozzi C
    Eur J Clin Pharmacol; 1980 Aug; 18(2):141-6. PubMed ID: 7428794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacology of pindolol.
    Aellig WH
    Am Heart J; 1982 Aug; 104(2 Pt 2):346-56. PubMed ID: 6125094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute cardiovascular activity of beta-adrenoceptor blocking drugs in awake or anaesthetized normotensive and hypertensive rats.
    Davy M; Midol-Monnet M; Cohen Y; Wepierre J
    Arch Int Pharmacodyn Ther; 1977 Dec; 230(2):257-78. PubMed ID: 603320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of beta-adrenergic blocking agents on the blood pressure, plasma renin activity and hemodynamics of hypertensive patients.
    Matsunaga M; Hara A; Ogino K; Motohara S; Saito M
    Jpn Heart J; 1977 Jan; 18(1):24-30. PubMed ID: 15142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of beta-adrenoceptor blocking compounds (propranolol, practolol and LB 46) on isoprenaline induced changes in regional blood flow in the rat.
    Debreczeni L; Fenyvesi T
    Br J Pharmacol; 1971 Feb; 41(2):171-6. PubMed ID: 4396701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the cardiovascular effects of pindolol in DOCA/saline hypertensive rats.
    Buckingham RE; Hamilton TC; Robson D
    Br J Pharmacol; 1977 Jul; 60(3):461-9. PubMed ID: 19118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemodynamic effects of some beta-adrenergic blocking agents in conscious spontaneously hypertensive rats (author's transl)].
    Matsunaga K; Ueda M
    Nihon Yakurigaku Zasshi; 1981 Jun; 77(6):597-604. PubMed ID: 6116655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of hypotensive mechanisms of pindolol, a beta-adrenoceptor blocking drugs in rats.
    Ozawa H; Matsubara T; Chen CS
    Jpn J Pharmacol; 1977 Apr; 27(2):295-302. PubMed ID: 18631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responses of the cardiovascular system of the rat to alpha-and beta-adrenoceptor agonists.
    Imms FJ; Neame RL; Powis DA
    Br J Pharmacol; 1977 May; 60(1):107-14. PubMed ID: 18244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Centrally induced hypotensive effects of beta-adrenergic blocking drugs.
    Garvey HL; Ram N
    Eur J Pharmacol; 1975; 33(2):283-94. PubMed ID: 241653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic interaction of chloralose pretreatment with subsequent beta-adrenergic receptor antagonism in lambs.
    Covert RF; Drummond WH
    Biol Neonate; 1994; 66(6):316-23. PubMed ID: 7727613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.